Study Shows More Deaths, No Benefit with Use of Hydroxychloroquine in COVID-19 Treatment

VA Study Shows No Success in Hydroxychloroquine Treatment, More Deaths

The Associated Press reports that a VA study on the effects of hydroxychloroquine in the treatment of coronavirus showed “no benefit in a large analysis of its use in U.S. veterans hospitals.” To add, the study concluded that there were more deaths among those given the drug compared to those who received standard care.

The anti-malaria drug has been widely touted by President Trump and right wing talking heads as a possible miracle treatment.

In regards to taking the drug, Trump recently asked viewers during a White House coronavirus briefing, “What do you have to lose?”

The answer? Your life, apparently.

The VA study is the largest thus far of its kind, though questions still remain.

The AP notes, “About 28% who were given hydroxychloroquine plus usual care died, versus 11% of those getting routine care alone. About 22% of those getting the drug plus azithromycin died too, but the difference between that group and usual care was not considered large enough to rule out other factors that could have affected survival.”

The study has been submitted to the New England Journal of Medicine, but has not yet been reviewed by other scientists.

Follow MeidasTouch on Twitter and Facebook for more.

Leave a Reply

Your email address will not be published. Required fields are marked *